Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer - PRNewswire

Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer  PRNewswire

Synspira's lead product targeting cystic fibrosis and other pulmonary diseases, SNSP113, to enter Phase 2 Clinical Trials in Second Half of 2019 - ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today